In clinical practice, alpha-fetoprotein (AFP), a glycoprotein, is a highly specific tumor marker for the detection of gastric cancer (37), serum indicators are available to predict the prognosis of gastric adenocarcinomas (38), and serum alpha-fetoprotein is one of the most extensively researched indicators (sAFP). This evidence concerns the gene AFP and gastric adenocarcinoma.